1 |
Angus DC,,Linde-Zwirble WT,,Lidicker J,et al.Epidemiology of severe sepsis in the United States:analysis of incidence,outcome,and associated costs of care[J]. Crit Care Med,2001,29(7):1303-1310.
|
2 |
Li W,,Wang M,,Zhu B,et al.Prediction of median survival time in sepsis patients by the SOFA score combined with different predictors[J].Burns Trauma,2020(8):tkz006.
|
3 |
Wang HE,,Shapiro NI,,Angus DC,et al.National estimates of severe sepsis in united states emergency departments[J].Crit Care Med,2007,35(8):1928-1936.
|
4 |
Fleischmann C,,Scherag A,,Adhikari NK,et al.Assessment of global incidence and mortality of hospital-treated sepsis. current estimates and limitations[J].Am J Respir Crit Care Med,2016,193(3):259-272.
|
5 |
Weng L,,Zeng XY,,Yin P,et al.Sepsis-related mortality in China:a descriptive analysis[J].Intensive Care Med,2018,44(7):1071-1080.
|
6 |
Rivers E,,Nguyen B,,Havstad S,et al.Early goal-directed therapy in the treatment of severe sepsis and septic shock[J].N Engl J Med,2001,345(19):1368-1377.
|
7 |
ProCESS Investigators, Yealy DM, Kellum JA,et al.A randomized trial of protocol-based care for early septic shock[J].N Engl J Med,2014,370(18):1683-1693.
|
8 |
De Backer D,,Dorman T.Surviving sepsis guidelines:a continuous move toward better care of patients with sepsis[J].JAMA,2017,317(8):807-808.
|
9 |
Dellinger RP,,Carlet JM,,Masur H,et al.Surviving sepsis campaign guidelines for management of severe sepsis and septic shock[J].Crit Care Med,2004,32(3):858-873.
|
10 |
Dellinger RP,,Levy MM,,Carlet JM,et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock:2008[J].Intensive Care Med,2008,34(1):17-60.
|
11 |
Dellinger RP,,Levy MM,,Rhodes A,et al.Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock:2012[J].Crit Care Med,201,41(2):580-637.
|
12 |
Howell MD,,Davis AM.Management of sepsis and septic shock[J].2017,317(8):847-848.
|
13 |
Rhodes A,,Evans LE,,Alhazzani W,et al.Surviving sepsis campaign:International guidelines for management of sepsis and septic shock:2016[J].Intensive Care Med,2017,43(3):304-377.
|
14 |
ProCESS Investigators,Yealy DM,,Kellum JA,et al.A randomized trial of protocol-based care for early septic shock[J].N Engl J Med,2014,370(18):1683-1693.
|
15 |
Mouncey PR,,Osborn TM,,Power GS,et al.Trial of early,goal-directed resuscitation for septic shock[J].N Engl J Med,2015,372(14):1301-1311.
|
16 |
Peake SL,,Delaney A,,Bailey M,et al.Goal-directed resuscitation for patients with early septic shock[J].N Engl J Med,2014,371(16):1496-1506.
|
17 |
Levy MM,,Evans LE,,Rhodes A.The surviving sepsis campaign bundle:2018 update[J].Crit Care Med,2018,46(6):997-1000.
|
18 |
Evans L,,Rhodes A,,Alhazzani W,et al.Surviving sepsis campaign:international guidelines for management of sepsis and septic shock 2021[J].Crit Care Med,2021,47(11):e1063-e1143.
|
19 |
Islam MM,,Nasrin T,,Walther BA,et al.Prediction of sepsis patients using machine learning approach:a meta-analysis[J].Comput Methods Programs Biomed,2019(170): 1-9.
|
20 |
Cecconi M,,Hernandez G,,Dunser M,et al.Fluid administration for acute circulatory dysfunction using basic monitoring:narrative review and expert panel recommendations from an ESICM task force[J].Intensive Care Med,2019,45(1):21-32.
|
21 |
Lara B,,Enberg L,,Ortega M,et al.Capillary refll time during fuid resuscitation in patients with sepsis-related hyperlactatemia at the emergency department is related to mortality[J].PLoS One,2017,12(11):e0188548.
|
22 |
Seymour CW,,Gesten F,,Prescott HC,et al.Time to treatment and mortality during mandated emergency care for sepsis[J].N Engl J Med,2017,376(23):2235-2244.
|
23 |
Sterling SA,,Miller WR,,Pryor J,et al.The impact of timing of antibiotics on outcomes in severe sepsis and septic shock:a systematic review and meta-analysis[J].Crit Care Med,2015,43(9):1907-1915.
|
24 |
Liu VX,,Fielding-Singh V,,Greene JD,et al.The timing of early antibiotics and hospital mortality in sepsis[J].Am J Respir Crit Care Med,2017,196(7):856-863.
|
25 |
Alam N,,Oskam E,,Stassen PM,et al.Prehospital antibiotics in the ambulance for sepsis:a multicentre,open label,randomized trial[J].Lancet Respir Med,2018,6(1):40-50.
|
26 |
Klein Klouwenberg PM,,Cremer OL,,van Vught LA,et al.Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission:a cohort study[J].Crit Care,2015,19(1):319.
|
27 |
Tidswell R,,Parker T,,Brealey D,et al.Sepsis-the broken code how accurately is sepsis being diagnosed?[J].J Infect,2020,81(6):e31-e32.
|
28 |
Mitchell KH,,Carlbom D,,Caldwell E,et al.Volume overload:prevalence,risk factors,and functional outcome in survivors of septic shock[J].Ann Am Thorac Soc 2015,12(12):1837-1844.
|
29 |
Moss SR,,Prescott HC.Current controversies in sepsis management[J].Semin Respir Crit Care Med,2019,40(5):594-603.
|
30 |
Bourgoin A,,Leone M,,Delmas A,et al.Increasing mean arterial pressure in patients with septic shock: effects on oxygen variables and renal function[J].Crit Care Med,2005,33(4):780-786.
|
31 |
Macdonald SPJ,,Taylor DM,,Keijzers G,et al.Restricted fluid resuscitation in sepsis-associated hypotension(REFRESH):study protocol for a pilot randomized controlled trial[J].Trial,2017,18(1):399.
|